Public Servant or Private Marketer? NIH Seeks Inquiry of Alzheimer’s researcher conflicts of interest

NIH: Public Servant or Private Marketer? NIH Seeks Outside Inquiry of Alzheimer’s researcher conflicts of interest – LAT Mon, 31 Jan 2005 A year after the Los Angeles Times published its first an in-depth investigative report documenting in detail evidence of major conflicts of interest by top scientists at the…

Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT

Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT Sun, 14 Mar 2004 Former Director of the National Institutes of Health, Harold Varmus, MD, appeared before a blue ribbon panel convened by his former agency, ostensibly to shed light on conflict of interest at…

Hemophiliacs File Suit Against Bayer for selling Tainted Blood product

Hemophiliacs File Suit Against Bayer for selling Tainted Blood product Tue, 3 Jun 2003 The Los Angeles Times reports that two weeks after The New York Times reported that Bayer documents reveal that the company sold tainted blood-clotting medicine for hemophiliacs that carried a high risk of transmitting AIDS to…

Investigative Press Reports

Investigative Press Reports Aug. 7, 2002: Los Angeles Times. UC Seeks to Ease Curbs on Patient Research, by Charles Ornstein and Rebecca Trounson http://www.latimes.com/features/health/medicine/la-me-uc7aug07.story?coll=la%2Dhealth%2Dmedicine SPECIAL REPORT : Experiments on Humans, San Francisco Chronicle August 4, 2002: Business of clinical trials soars, but risks unknown Medical studies give new hope to…

|

FDA Cut Off Critic’s Access to Drug Safety Database – Chicago Tribune

FDA Cut Off Critic’s Access to Drug Safety Database – Chicago Tribune Thu, 24 Feb 2005 The Chicago Tribune reports (below) about an eggregious example of the abuse of power by FDA officials who are retaliating against an independent scientist whose unique research project for detecting rare adverse drug reactions…

NIH ethics review

NIH ethics review Thu, 15 Jan 2004 There is nothing quite like good investigative journalism to shake public officials from their complacency. An investigative report by David Willman in The Los Angeles Times on Dect 7, 2003, has sent NIH director, Dr. Elias Zirhouni, scrambling to explain why NIH has…

NIH Panel Recommendations Fail to Resolve Conflicts of Interest

NIH Panel Recommendations Fail to Resolve Conflicts of Interest Date: Fri, 7 May 2004 Following the disclosure by the Los Angeles Times (December 2003) that “NIH officials now allow more than 94% of the agency’s top-paid employees to keep their consulting income confidential,” Congress demanded full disclosure and an overhaul…

Critics of NIH Studies Prompt Senate Hearing – WashPost

Critics of NIH Studies Prompt Senate Hearing – WashPost Mon, 19 Jan 2004 Accountability is a controversial concept for officials at the National Institutes of Health (NIH). Dr. Elias Zirhouni, director of NIH, is scrambling to explain recent revelations of impropriety: First, the agency approved taxpayer money for highly questionable…

NIH Conflict of Interest Rules – "Option of Corruption" – children victimized

NIH Conflict of Interest Rules_”Option of Corruption”_ children victimized Tue, 18 May 2004 Lawmakers accused leaders of the National Institutes of Health of encouraging “the option of corruption.” NIH medical researchers, who receive the highest salaries in government, think they, unlike others, are entitled to moonlight while employed at taxpayers…

10 of 32 FDA Vioxx Panelists Had Industry Ties / Cozy NIH Review "Clears" NIH Industry Ties

10 of 32 FDA Vioxx Panelists Had Industry Ties_NYT / Cozy NIH Review “Clears” NIH Industry Ties_WashPost Fri, 25 Feb 2005 The latest example of the corrupting influence of the pharmaceutical industry on health care policy is the composition of FDA’s advisory panel that last week endorsed the marketing of…